|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00314 SIPAI HEALTH
Nominal 
2.130 +0.010 (+0.472%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -6.425% | -12.745% | -8.905% | -47.079% | -139.273% |
| ROAE (%) | -11.495% | -22.760% | -14.802% | N/A | N/A |
| Return on Capital Employed (%) | -13.616% | -26.348% | -15.287% | -73.128% | -181.398% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 15.033% | 8.464% | 8.801% | 8.189% | 8.159% |
| EBITDA Margin (%) | -5.218% | -7.106% | -4.672% | -32.348% | -106.525% |
| Pre-tax Profit Margin (%) | -6.188% | -7.899% | -5.214% | -33.219% | -107.880% |
| Net Profit Margin (%) | -6.000% | -7.091% | -5.428% | -33.271% | -107.672% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 1.829 X | 1.910 X | 2.139 X | 2.554 X | 2.995 X |
| Quick Ratio (X) | 1.732 X | 1.723 X | 1.923 X | 2.288 X | 2.671 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 43.851% | 46.957% | 42.056% | 37.392% | 287.738% |
| Total Debt / Total Assets (%) | 1.409% | 2.008% | 2.400% | 2.313% | 3.008% |
| Net Debt / Total Assets (%) | -14.759% | -9.157% | -15.199% | -47.369% | -15.515% |
| Total Debt / Shareholders' Funds (%) | 2.411% | 3.711% | 4.173% | 3.689% | N/A |
| Long Term Debt / Shareholders' Funds (%) | 1.347% | 2.102% | 2.430% | 2.109% | N/A |
| Net Debt / Shareholders' Funds (%) | -25.266% | -16.921% | -26.430% | -75.545% | N/A |
| Net Cash / (Debt) ($) | 236.567M | 207.425M | 427.868M | 1.388B | 448.831M |
| Net Cash / (Debt) per share ($) | 0.316 | 0.271 | 0.562 | 1.819 | -- |
| Total Debt / Capital Employed (%) | 2.474% | 3.703% | 4.038% | 3.616% | 4.220% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 27.035 Day | 19.197 Day | 22.354 Day | 26.509 Day | 31.402 Day |
| Receivables Turnover (Day) | 37.999 Day | 24.225 Day | 22.123 Day | 18.272 Day | 11.337 Day |
| Payables Turnover (Day) | 46.827 Day | 35.060 Day | 31.151 Day | 25.571 Day | 24.566 Day |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -124,267 |
| %Change | -61.615% |
| EPS / (LPS) | RMB -0.210 |
| NBV Per Share (¥) | RMB 1.249 |